How should I stop using ruxolitinib ointment?

When using ruxolitinib ointment (Opzelura), discontinuation should be done carefully to ensure that symptoms do not return or worsen. The correct way to discontinue medication should be carried out under the guidance of a doctor and adjusted according to changes in individual condition and treatment response.

Discontinuation of medication should not be sudden, especially when symptoms are newly under control. Abrupt discontinuation may lead to relapse or rebound effects, especially in patients with chronic skin diseases such as atopic dermatitis or vitiligo. Therefore, it is usually recommended to gradually reduce the frequency of medication after significant improvement in symptoms. For example, if a patient originally uses ruxolitinib ointment twice a day, it can be gradually reduced to once a day, and then to once every other day under the advice of a doctor, until the drug is finally discontinued.

During the withdrawal period, patients should closely observe skin changes. If there are signs of recurrence or worsening of symptoms during the tapering process, the tapering should be stopped immediately and a doctor should be consulted. In this case, it may be necessary to resume the original medication frequency or use other alternative treatments to control the condition.

Also, it is important to maintain skin care during withdrawal. Patients can use moisturizers to maintain the integrity of the skin barrier and reduce the occurrence of dry skin and irritation. Good skin care can help maintain the effects of treatment after discontinuation and reduce the risk of recurrence.

For some patients, doctors may recommend regular follow-up visits after discontinuation of medication to monitor skin conditions and restart treatment if necessary. Especially for patients with vitiligo, the pigment recovery after stopping the drug may need further evaluation, and the doctor will adjust the subsequent treatment plan according to the specific situation.